Healthcare Digital July 8, 2024
Sean Ashcroft

Nestlé Health Science launches nutrition initiative to counteract side effects of weight-loss drugs, including hollowed-out ‘Ozempic Face’

The surge in sales of weight loss drugs – particularly in the US – is having a ripple effect on other markets, both in the foods and healthcare sectors.

Weight loss drugs are believed to be behind a fall in demand for the kind of foods associated with weight gain. Analysts at Morgan Stanley estimate that US consumption of fizzy soft drinks, baked goods and salty snacks could fall by up to 3% by 2035.

These drugs are also reshaping the healthcare industry, as people seek solutions to some of the unwanted cosmetic effects of rapid weight loss.

One such effect is so-called...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Provider, Retailer
Learning from Past Failures: Challenges Faced by Non-Traditional Players in the Health Care Industry
AI Glasses From Snap and Meta May Reshape How We Shop
What Will the Future of Retail Health Look Like?
Walmart and Amazon Race to Capture GenAI Opportunity
What Healthcare Can Learn from Costco

Share This Article